Life Biosciences
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Life Biosciences - overview
Established
2017
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2017, Life Biosciences Inc. , a. k. a.
Life Biosciences operates as a life sciences company that focuses on discovering and developing novel therapies to improve the lives of people as they age. The company was co-founded by Tristan Edwards and David A. Sinclair, PhD, AO, who is also listed by the company as chairman and co-founder. In April 2026, Life Biosciences Inc.
raised USD 80 million in series D funding. As of May 2024, Jerry McLaughlin is the CEO of the company The company leverages its partial epigenetic reprogramming platform to reprogram the epigenome to resemble that of younger animals using Yamanaka factors, demonstrating success in restoring vision and nerve regeneration in preclinical models. Life Biosciences also utilizes a chaperone-mediated autophagy platform that enhances the degradation of unwanted proteins by increasing the expression of proteins like LAMP2A, showing efficacy in models of frontotemporal dementia, Alzheimer’s disease, and retinal degeneration. These approaches enable Life Biosciences to address unmet medical needs in aging-related diseases.
The company will use the April 2026 funding to support operations into the second half of 2027, complete its Phase 1 clinical trial of ER-100, and advance its Partial Epigenetic Reprogramming platform across multiple therapeutic indications.
Current Investors
LeFrak, Alpha Wave Global, Gaingels
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Bioinformatics, Pharmaceutical Research & Development
Website
www.lifebiosciences.com
Company Stage
Series D
Total Amount Raised
Subscriber access only
Life Biosciences - employee data
Life Biosciences - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.